SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Charles Holewinski who wrote (286)7/23/1997 3:29:00 AM
From: luis a. garcia   of 1115
 
Well Charles I am going to bed.. did not confirm your recollection of FDA ruling on over the counter status for LIDAKOL one way or the other.

Did come across lots and lots of licencing renewals all the old buds come back to the fold.. Bristol Myers Squibb the U.S. Mexico and Canada. Yamanouchi has Europe,Africa and Middle East. Greeland Pharmaceutical has Japan. Boryiung has Korea. CTS industries has Israel. New partners to be licenced in China and South and Central America and India.

And yet ... the company is expected to burn cash for a while but then milestone royalty payments are due upon completion of certain milestones...
gets confusing.....I would think if Lidakol becomes a drug Lidak would be in the black???? S&P says it thinks not????? can anybody make sense
of this??? a global over the counter(maybe) drug like this and no profit???? impossible..

luis
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext